J. Cancer
Overall survival, progression free survival and objective response rate. Overall survival is the key patient-relevant outcome. Clinical claim. In adult patients with metastatic clear cell variant RCC who experience disease progression on or after prior VEGFR-targeted treatment: Compared with everolimus, cabozantinib is superior in terms of effectiveness (PFS, OS and ORR), and is non-inferior ... ................
................
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.